Xyratex Ltd XRTX 深 沪
已收盘 08-29 16:00:00 美东时间
0.8044
-0.025
-3.07%
华盛通- 最 高0.82
- 今 开0.8109
- 成交量 4.43万股
- 最 低 0.79
- 昨 收 0.8299
- 总市值 304.72万
- 52周最高 2.51
- 市盈率 静 --
- 换手率 1.17%
- 52周最低 0.6608
- 委 比 65.12%
- 总股本 378.82万
- 历史最高 53.01
- 量 比 1.73
- 振 幅 3.61%
- 历史最低 0.6608
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therap...
08-09 08:38
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026
<p>XORTX Therapeutics Inc. reported significant progress in its gout and kidney disease therapies, with a focus on advancing its XRx-026 program using the XORLO™ formulation. The company achieved considerable milestones in 2025, including FDA engagement, patent advancements, leadership appointments, and expanded funding. XORTX aims to file an NDA for XORLO™ within 12 months, targeting a $700 million market. Key 2026 goals include IND submission, ...
08-07 11:00
XORTX Completes Non-Brokered Private Placement of Units
XORTX Therapeutics Inc. 完成了非公开发行，共发行1,267,123个单位，筹集92.5万美元。每个单位含一股普通股和一个5年期认股权证（行权价1.20美元），如股价连续10天超2.00美元，认股权证将加速到期。此次发行未设4个月加一天持有期，资金用于痛风项目及一般公司运营。公司向内部人士发行8,191个单位，未违反MI 61-101规定。此外，终止了早前宣布的非公开发行。
07-22 23:59
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) rose sharply in today's pre-m...
07-07 18:26
XORTX Therapeutics Announces Non-Brokered Private Placement To Raise Up To $925K Through Issuance Of Up To 1.27M Common Share Units At $0.73/Unit
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
06-26 19:14
XORTX Announces USD $925,000 Private Placement
XORTX Therapeutics is conducting a non-brokered private placement to raise up to USD $925,000 by issuing up to 1,267,123 common share units at USD $0.73 per unit. Each unit includes one common share and one warrant, exercisable at USD $1.20 until 60 months post-closing, or 30 days after notice if the share price exceeds USD $2.00 for 10 consecutive days. The offering is targeted at Canadian residents (excluding Quebec) and other qualifying jurisd...
06-26 11:00
XORTX Therapeutics looks to raise $3M through private placement
XORTX Therapeutics (NASDAQ:XRTX) said it was looking to raise $3M through a non-brokered private placement. The firm planned to issue up to 3.41M share units at a price of $0.88 apiece. Each unit w...
05-19 19:16
XORTX Therapeutics receives Nasdaq notice for non-compliance
Late stage clinical pharmaceutical company XORTX Therapeutics (NASDAQ:XRTX) received notification from the Nasdaq that it is not in compliance with the minimum bid price requirement since the closin...
04-18 14:45
XORTX Receives Nasdaq Notification for Minimum Bid Price Deficiency
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has issued an announcement. XORTX Therap...
04-18 08:32
XORTX Therapeutics Releases Annual Information Form for 2024
XORTX Therapeutics Inc ( ($TSE:XRTX) ) just unveiled an update. On March 31, 20...
04-02 03:57
